Tempest Therapeutics, Inc.

TPST

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001544227

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

21

−1 vs. Q1 2026
Total value $1.44M

View 13F holders

Superinvestors holding TPST

0

None of the superinvestors held TPST at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by TPST insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jun 23, 2026	Mar 24, 2026	Angel MatthewCEO and President	PPurchaseCommon Stock	+231.48K	$2.16	+$500K	231.48K	New position	SEC
Jun 23, 2026	Mar 24, 2026	Angel MatthewCEO and President	PPurchaseCommon Stock · Derivative	+462.96K	–	–	231.48K	–	SEC
Mar 25, 2026	Mar 24, 2026	Angel MatthewCEO and President	PPurchaseCommon Stock	+231.48K	$2.16	+$500K	231.48K	New position	SEC
Aug 12, 20248:33 PM ET	Aug 8 – Aug 12, 2024	Versant Ventures IV, LLC and 8 others10% Owner	SSaleCommon Stock	−788K	$1.2272	−$967.03K	209.94K	−79.0%	SEC
Jul 8, 2024	Jul 3, 2024	Brady Stephen RPresident and CEO	PPurchaseCommon Stock	+35K	$2.11	+$73.85K	46.38K	+307.7%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in TPST at the end of Q2 2026.

Institutions holding TPST in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
SABBY MANAGEMENT, LLC	511,286	$567.53K	4.72%	+493,430+2,763.4%	Added
Versant Venture Management, LLC	269,772	$299.45K	0.18%	00.0%	Unchanged
VANGUARD CAPITAL MANAGEMENT LLC	233,888	$259.62K	0.00%	00.0%	Unchanged
GEODE CAPITAL MANAGEMENT, LLC	86,625	$96.16K	0.00%	−365−0.4%	Reduced
VANGUARD FIDUCIARY TRUST CO	68,908	$76.49K	0.00%	00.0%	Unchanged